| Sign In to gain access to subscriptions and/or personal tools. |
Griscelli Syndrome Type 2: A Rare and Lethal DisorderDepartment of Pediatrics, Division of child Neurology, Jordan University Hospital, amasri{at}ju.edu.jo
Department of Medicine, Division of Infectious Diseases, Jordan University Hospital
Department of Pathology, The National Center for Diabetes, Endocrinology, and Gentics Amman
Department of Radiology, Jordan University Hospital
Department of Pediatrics Jordan University Hospital
Lab. d'Immuno-Hématologie Pédiatrique, Hôpital Necker-Enfants Malades, Paris, France
King Hussein Cancer Center, The National Center for Diabetes, Endocrinology, and Genetics Amman, Jordan Griscelli syndrome is a rare autosomal recessive disorder. It is characterized by pigment dilution and variable immune deficiency leading to increased susceptibility to certain infections and a tendency to develop a life-threatening hemophagocytic syndrome known as the accelerated phase. Griscelli syndrome is now classified into 3 types based on the genetic and molecular features. Primary neurological presentation without the accelerated phase is rare in type 2. In this article, the authors report a boy who was presented with seizures and diffuse white matter involvement unaccompanied by the other features of the accelerated phase. Mutation analysis in family members revealed the presence of a missense mutation in Rab27a gene. In addition to the rare presentation, this is the first case of Griscelli syndrome to be reported from Jordan.
Key Words: Griscelli syndrome Rab27a hemophagocytic syndrome
This version was published on August
1, 2008 Journal of Child Neurology, Vol. 23, No. 8,
964-967 (2008) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

